Pacira BioSciences, Inc. — Director's Dealing 2016

Jan 30, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pacira Pharmaceuticals, Inc. (PCRX)
CIK: 0001396814
Period of Report: 2016-01-27

Reporting Person: Jones James B (SVP & Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-01-27	Common Stock	P	500	$62.50	Acquired	1500	Direct